Hotline: +86-18022463983    020-85206863

China Asthma & COPD Market Report & Forecast 2021-2027

Published Date: 2021-10-08   |   Pages: 93   |   Tables: 101   |  Pharma & Healthcare

This report contains market size and forecasts of Asthma & COPD in China, including the following market information:

China Asthma & COPD Market Revenue, 2016-2021, 2022-2027, ($ millions)

China Asthma & COPD Market Sales, 2016-2021, 2022-2027, (K Units)

China top five Asthma & COPD companies in 2020 (%)

The global Asthma & COPD market size is expected to growth from US$ XX million in 2020 to US$ XX million by 2027; it is expected to grow at a CAGR of XX% during 2021-2027.

The China Asthma & COPD market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.

QYResearch has surveyed the Asthma & COPD manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

China Asthma & COPD Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)

China Asthma & COPD Market Segment Percentages, By Type, 2020 (%)

Anti-inflammatory Drugs

Bronchodilator Monotherapy

Combination Drugs

China Asthma & COPD Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)

China Asthma & COPD Market Segment Percentages, By Application, 2020 (%)

Hospital Pharmacies

Private Clinics

Drug Stores

Retail Pharmacies

E-Commerce

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Asthma & COPD revenues in China market, 2016-2021 (Estimated), ($ millions)

Key companies Asthma & COPD revenues share in China market, 2020 (%)

Key companies Asthma & COPD sales in China market, 2016-2021 (Estimated), (K Units)

Key companies Asthma & COPD sales share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

GSK

Novartis

Merck

Abbott

Boehringer Ingelheim

AstraZeneca

Roche

Teva

Vectura

Pfizer

Mylan

Allergan

Cipla

Akorn

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Introduction to Research & Analysis Reports

1.1 Asthma & COPD Market Definition

1.2 Market Segments

1.2.1 Segment by Type

1.2.2 Segment by Application

1.3 China Asthma & COPD Market Overview

1.4 Methodology & Sources of Information

1.4.1 Research Methodology

1.4.2 Research Process

1.4.3 Base Year

2 China Asthma & COPD Overall Market Size

2.1 China Asthma & COPD Market Size: 2021 VS 2027

2.2 China Asthma & COPD Revenue, Prospects & Forecasts: 2016-2027

2.3 China Asthma & COPD Sales: 2016-2027

3 Company Landscape

3.1 Top Asthma & COPD Players in China Market

3.2 Top China Asthma & COPD Companies Ranked by Revenue

3.3 China Asthma & COPD Revenue by Companies

3.4 China Asthma & COPD Sales by Companies

3.5 China Asthma & COPD Price by Manufacturer (2016-2021)

3.6 Top 3 and Top 5 Asthma & COPD Companies in China Market, by Revenue in 2020

3.7 Manufacturers Asthma & COPD Product Type

3.8 Tier 1, Tier 2 and Tier 3 Asthma & COPD Players in China Market

3.8.1 List of Tier 1 Asthma & COPD Companies in China

3.8.2 List of Tier 2 and Tier 3 Asthma & COPD Companies in China

4 Sights by Type

4.1 Overview

4.1.1 By Type - China Asthma & COPD Market Size Markets, 2021 & 2027

4.1.2 Anti-inflammatory Drugs

4.1.3 Bronchodilator Monotherapy

4.1.4 Combination Drugs

4.2 By Type - China Asthma & COPD Revenue & Forecasts

4.2.1 By Type - China Asthma & COPD Revenue, 2016-2021

4.2.2 By Type - China Asthma & COPD Revenue, 2022-2027

4.2.3 By Type - China Asthma & COPD Revenue Market Share, 2016-2027

4.3 By Type - China Asthma & COPD Sales & Forecasts

4.3.1 By Type - China Asthma & COPD Sales, 2016-2021

4.3.2 By Type - China Asthma & COPD Sales, 2022-2027

4.3.3 By Type - China Asthma & COPD Sales Market Share, 2016-2027

4.4 By Type - China Asthma & COPD Price (Manufacturers Selling Prices), 2016-2027

5 Sights by Application

5.1 Overview

5.1.1 By Application - China Asthma & COPD Market Size, 2021 & 2027

5.1.2 Hospital Pharmacies

5.1.3 Private Clinics

5.1.4 Drug Stores

5.1.5 Retail Pharmacies

5.1.6 E-Commerce

5.2 By Application - China Asthma & COPD Revenue & Forecasts

5.2.1 By Application - China Asthma & COPD Revenue, 2016-2021

5.2.2 By Application - China Asthma & COPD Revenue, 2022-2027

5.2.3 By Application - China Asthma & COPD Revenue Market Share, 2016-2027

5.3 By Application - China Asthma & COPD Sales & Forecasts

5.3.1 By Application - China Asthma & COPD Sales, 2016-2021

5.3.2 By Application - China Asthma & COPD Sales, 2022-2027

5.3.3 By Application - China Asthma & COPD Sales Market Share, 2016-2027

5.4 By Application - China Asthma & COPD Price (Manufacturers Selling Prices), 2016-2027

6 Manufacturers & Brands Profiles

6.1 GSK

6.1.1 GSK Corporation Information

6.1.2 GSK Overview

6.1.3 GSK Asthma & COPD Sales and Revenue in China Market (2016-2021)

6.1.4 GSK Asthma & COPD Product Description

6.1.5 GSK Recent Developments

6.2 Novartis

6.2.1 Novartis Corporation Information

6.2.2 Novartis Overview

6.2.3 Novartis Asthma & COPD Sales and Revenue in China Market (2016-2021)

6.2.4 Novartis Asthma & COPD Product Description

6.2.5 Novartis Recent Developments

6.3 Merck

6.3.1 Merck Corporation Information

6.3.2 Merck Overview

6.3.3 Merck Asthma & COPD Sales and Revenue in China Market (2016-2021)

6.3.4 Merck Asthma & COPD Product Description

6.3.5 Merck Recent Developments

6.4 Abbott

6.4.1 Abbott Corporation Information

6.4.2 Abbott Overview

6.4.3 Abbott Asthma & COPD Sales and Revenue in China Market (2016-2021)

6.4.4 Abbott Asthma & COPD Product Description

6.4.5 Abbott Recent Developments

6.5 Boehringer Ingelheim

6.5.1 Boehringer Ingelheim Corporation Information

6.5.2 Boehringer Ingelheim Overview

6.5.3 Boehringer Ingelheim Asthma & COPD Sales and Revenue in China Market (2016-2021)

6.5.4 Boehringer Ingelheim Asthma & COPD Product Description

6.5.5 Boehringer Ingelheim Recent Developments

6.6 AstraZeneca

6.6.1 AstraZeneca Corporation Information

6.6.2 AstraZeneca Overview

6.6.3 AstraZeneca Asthma & COPD Sales and Revenue in China Market (2016-2021)

6.6.4 AstraZeneca Asthma & COPD Product Description

6.6.5 AstraZeneca Recent Developments

6.7 Roche

6.7.1 Roche Corporation Information

6.7.2 Roche Overview

6.7.3 Roche Asthma & COPD Sales and Revenue in China Market (2016-2021)

6.7.4 Roche Asthma & COPD Product Description

6.7.5 Roche Recent Developments

6.8 Teva

6.8.1 Teva Corporation Information

6.8.2 Teva Overview

6.8.3 Teva Asthma & COPD Sales and Revenue in China Market (2016-2021)

6.8.4 Teva Asthma & COPD Product Description

6.8.5 Teva Recent Developments

6.9 Vectura

6.9.1 Vectura Corporation Information

6.9.2 Vectura Overview

6.9.3 Vectura Asthma & COPD Sales and Revenue in China Market (2016-2021)

6.9.4 Vectura Asthma & COPD Product Description

6.9.5 Vectura Recent Developments

6.10 Pfizer

6.10.1 Pfizer Corporation Information

6.10.2 Pfizer Overview

6.10.3 Pfizer Asthma & COPD Sales and Revenue in China Market (2016-2021)

6.10.4 Pfizer Asthma & COPD Product Description

6.10.5 Pfizer Recent Developments

6.11 Mylan

6.11.1 Mylan Corporation Information

6.11.2 Mylan Overview

6.11.3 Mylan Asthma & COPD Sales and Revenue in China Market (2016-2021)

6.11.4 Mylan Asthma & COPD Product Description

6.11.5 Mylan Recent Developments

6.12 Allergan

6.12.1 Allergan Corporation Information

6.12.2 Allergan Overview

6.12.3 Allergan Asthma & COPD Sales and Revenue in China Market (2016-2021)

6.12.4 Allergan Asthma & COPD Product Description

6.12.5 Allergan Recent Developments

6.13 Cipla

6.13.1 Cipla Corporation Information

6.13.2 Cipla Overview

6.13.3 Cipla Asthma & COPD Sales and Revenue in China Market (2016-2021)

6.13.4 Cipla Asthma & COPD Product Description

6.13.5 Cipla Recent Developments

6.14 Akorn

6.14.1 Akorn Corporation Information

6.14.2 Akorn Overview

6.14.3 Akorn Asthma & COPD Sales and Revenue in China Market (2016-2021)

6.14.4 Akorn Asthma & COPD Product Description

6.14.5 Akorn Recent Developments

7 China Asthma & COPD Production Capacity, Analysis

7.1 China Asthma & COPD Production Capacity, 2016-2027

7.2 Asthma & COPD Production Capacity of Key Manufacturers in China Market

8 Key Market Trends, Opportunity, Drivers and Restraints

8.1 Market Opportunities & Trends

8.2 Market Drivers

8.3 Market Restraints

9 Asthma & COPD Supply Chain Analysis

9.1 Asthma & COPD Industry Value Chain

9.2 Asthma & COPD Upstream Market

9.3 Asthma & COPD Downstream and Clients

9.4 Marketing Channels Analysis

9.4.1 Marketing Channels

9.4.2 Asthma & COPD Distributors and Sales Agents in China Market

10 Conclusion

11 Appendix

11.1 Note

11.2 Examples of Clients

11.3 Author Details

11.4 Disclaimer

List of Tables

Table 1. Key Players of Asthma & COPD in China Market

Table 2. Top Asthma & COPD Players in China Market, Ranking by Revenue (2019)

Table 3. China Asthma & COPD Revenue by Companies, (US$, Mn), 2016-2021

Table 4. China Asthma & COPD Revenue Share by Companies, 2016-2021

Table 5. China Asthma & COPD Sales by Companies, (K Units), 2016-2021

Table 6. China Asthma & COPD Sales Share by Companies, 2016-2021

Table 7. Key Manufacturers Asthma & COPD Price (2016-2021) & (USD/Unit)

Table 8. Manufacturers Asthma & COPD Product Type

Table 9. List of Tier 1 Asthma & COPD Companies, Revenue (US$, Mn) in 2020 and Market Share

Table 10. List of Tier 2 and Tier 3 Asthma & COPD Companies, Revenue (US$, Mn) in 2020 and Market Share

Table 11. Major Manufacturers of Anti-inflammatory Drugs

Table 12. Major Manufacturers of Bronchodilator Monotherapy

Table 13. By Type – China Asthma & COPD Revenue, (US$, Mn), 2021 & 2027

Table 14. By Type - China Asthma & COPD Revenue (US$, Mn), 2016-2021

Table 15. By Type - China Asthma & COPD Revenue (US$, Mn), 2022-2027

Table 16. By Type - China Asthma & COPD Sales (K Units), 2016-2021

Table 17. By Type - China Asthma & COPD Sales (K Units), 2022-2027

Table 18. By Application – China Asthma & COPD Revenue, (US$, Mn), 2021 VS 2027

Table 19. By Application - China Asthma & COPD Revenue (US$, Mn), 2016-2021

Table 20. By Application - China Asthma & COPD Revenue (US$, Mn), 2022-2027

Table 21. By Application - China Asthma & COPD Sales (K Units), 2016-2021

Table 22. By Application - China Asthma & COPD Sales (K Units), 2022-2027

Table 23. GSK Corporation Information

Table 24. GSK Description and Major Businesses

Table 25. GSK Asthma & COPD Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 26. GSK Asthma & COPD Product

Table 27. GSK Recent Developments

Table 28. Novartis Corporation Information

Table 29. Novartis Description and Major Businesses

Table 30. Novartis Asthma & COPD Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 31. Novartis Asthma & COPD Product

Table 32. Novartis Recent Developments

Table 33. Merck Corporation Information

Table 34. Merck Description and Major Businesses

Table 35. Merck Asthma & COPD Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 36. Merck Asthma & COPD Product

Table 37. Merck Recent Developments

Table 38. Abbott Corporation Information

Table 39. Abbott Description and Major Businesses

Table 40. Abbott Asthma & COPD Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 41. Abbott Asthma & COPD Product

Table 42. Abbott Recent Developments

Table 43. Boehringer Ingelheim Corporation Information

Table 44. Boehringer Ingelheim Description and Major Businesses

Table 45. Boehringer Ingelheim Asthma & COPD Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 46. Boehringer Ingelheim Asthma & COPD Product

Table 47. Boehringer Ingelheim Recent Developments

Table 48. AstraZeneca Corporation Information

Table 49. AstraZeneca Description and Major Businesses

Table 50. AstraZeneca Asthma & COPD Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 51. AstraZeneca Asthma & COPD Product

Table 52. AstraZeneca Recent Developments

Table 53. Roche Corporation Information

Table 54. Roche Description and Major Businesses

Table 55. Roche Asthma & COPD Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 56. Roche Asthma & COPD Product

Table 57. Roche Recent Developments

Table 58. Teva Corporation Information

Table 59. Teva Description and Major Businesses

Table 60. Teva Asthma & COPD Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 61. Teva Asthma & COPD Product

Table 62. Teva Recent Developments

Table 63. Vectura Corporation Information

Table 64. Vectura Description and Major Businesses

Table 65. Vectura Asthma & COPD Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 66. Vectura Asthma & COPD Product

Table 67. Vectura Recent Developments

Table 68. Pfizer Corporation Information

Table 69. Pfizer Description and Major Businesses

Table 70. Pfizer Asthma & COPD Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 71. Pfizer Asthma & COPD Product

Table 72. Pfizer Recent Developments

Table 73. Mylan Corporation Information

Table 74. Mylan Description and Major Businesses

Table 75. Mylan Asthma & COPD Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 76. Mylan Asthma & COPD Product

Table 77. Mylan Recent Developments

Table 78. Allergan Corporation Information

Table 79. Allergan Description and Major Businesses

Table 80. Allergan Asthma & COPD Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 81. Allergan Asthma & COPD Product

Table 82. Allergan Recent Developments

Table 83. Cipla Corporation Information

Table 84. Cipla Description and Major Businesses

Table 85. Cipla Asthma & COPD Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 86. Cipla Asthma & COPD Product

Table 87. Cipla Recent Developments

Table 88. Akorn Corporation Information

Table 89. Akorn Description and Major Businesses

Table 90. Akorn Asthma & COPD Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)

Table 91. Akorn Asthma & COPD Product

Table 92. Akorn Recent Developments

Table 93. Asthma & COPD Production Capacity (K Units) of Key Manufacturers in China Market, 2019-2021 (K Units)

Table 94. China Asthma & COPD Capacity Market Share of Key Manufacturers, 2019-2021

Table 95. Asthma & COPD Market Opportunities & Trends in China Market

Table 96. Asthma & COPD Market Drivers in China Market

Table 97. Asthma & COPD Market Restraints in China Market

Table 98. Asthma & COPD Raw Materials

Table 99. Asthma & COPD Raw Materials Suppliers in China Market

Table 100. Typical Asthma & COPD Downstream

Table 101. Asthma & COPD Downstream Clients in China Market

Table 102. Asthma & COPD Distributors and Sales Agents in China Market

List of Figures

Figure 1. Asthma & COPD Product Picture

Figure 2. Asthma & COPD Segment by Type

Figure 3. Asthma & COPD Segment by Application

Figure 4. China Asthma & COPD Market Overview: 2020

Figure 5. China Asthma & COPD Market Size: 2021 VS 2027 (US$, Mn)

Figure 6. China Asthma & COPD Revenue, 2016-2027 (US$, Mn)

Figure 7. Asthma & COPD Sales in China Market: 2016-2027 (K Units)

Figure 8. The Top 3 and 5 Players Market Share by Asthma & COPD Revenue in 2020

Figure 9. Anti-inflammatory Drugs Product Picture

Figure 10. Bronchodilator Monotherapy Product Picture

Figure 11. Combination Drugs Product Picture

Figure 12. By Type - China Asthma & COPD Sales Market Share, 2016-2027

Figure 13. By Type - China Asthma & COPD Revenue Market Share, 2016-2027

Figure 14. By Type - China Asthma & COPD Price (USD/Unit), 2016-2027

Figure 15. Hospital Pharmacies

Figure 16. Private Clinics

Figure 17. Drug Stores

Figure 18. Retail Pharmacies

Figure 19. E-Commerce

Figure 20. By Application - China Asthma & COPD Sales Market Share, 2016-2027

Figure 21. By Application - China Asthma & COPD Revenue Market Share, 2016-2027

Figure 22. By Application - China Asthma & COPD Price (USD/Unit), 2016-2027

Figure 23. GSK Asthma & COPD Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 24. Novartis Asthma & COPD Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 25. Merck Asthma & COPD Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 26. Abbott Asthma & COPD Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 27. Boehringer Ingelheim Asthma & COPD Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 28. AstraZeneca Asthma & COPD Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 29. Roche Asthma & COPD Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 30. Teva Asthma & COPD Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 31. Vectura Asthma & COPD Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 32. Pfizer Asthma & COPD Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 33. Mylan Asthma & COPD Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 34. Allergan Asthma & COPD Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 35. Cipla Asthma & COPD Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 36. Akorn Asthma & COPD Revenue Year Over Year Growth (US$, Mn) & (2016-2021)

Figure 37. China Asthma & COPD Production Capacity (K Units), 2016-2027

Figure 38. Asthma & COPD Industry Value Chain

Figure 39. Marketing Channels

Our Clients